High-purity pharmaceutical raw materials and specialized bioactive compounds engineered to global regulatory compliance standards.
Comprehensive chemical profile, structural characterization, and analytical standards for enterprise pharmaceutical manufacturing.
Hydroxychloroquine Sulphate (CAS Number: 747-36-4) is a white or practically white, crystalline powder chemically designated as 2-[[4-[(7-chloroquinolin-4-yl)amino]pentyl](ethyl)amino]ethanol sulfate. As an 4-aminoquinoline derivative, it acts as a potent lysosomotropic agent with wide-ranging applications in rheumatology, immunology, and infectious disease therapies.
Our raw powder material is synthesized via optimized green chemical pathways, ensuring exceptionally low organic impurity levels and precise control over particle size distribution (PSD). Designed specifically for oral solid dosage (OSD) formulations, our active pharmaceutical ingredient (API) meets and exceeds all criteria outlined in current USP, EP, BP, and IP monographs.
Hydroxychloroquine Sulphate exerts multi-factorial cellular actions:
| Analytical Parameter | Specification Standard | Testing Methodology |
|---|---|---|
| Chemical Name | Hydroxychloroquine Sulfate / Hydroxychloroquine Sulphate | IUPAC Nomenclature |
| CAS Registry Number | 747-36-4 | CAS Chemical Index |
| Molecular Formula / Weight | C18H26ClN3O · H2SO4 / 433.95 g/mol | Mass Spectrometry (MS) |
| Assay (Purity Standard) | 99.0% – 101.0% (Dried Basis) | HPLC / Volumetric Titration |
| Appearance | White to Off-White Crystalline Powder | Visual Inspection |
| Related Substances / Impurities | Individual Impurity ≤ 0.10%, Total Impurities ≤ 0.50% | High-Performance Liquid Chromatography |
| Heavy Metals & Residue on Ignition | Heavy Metals ≤ 10 ppm, Ignition Residue ≤ 0.1% | ICP-MS / Gravimetric |
| Particle Size Distribution | Standard: d90 < 100μm | Micronized Grade Available | Laser Diffraction (Malvern) |
Navigating regulatory shifting parameters, raw material security, and green chemistry innovation in antimalarial and autoimmune APIs.
The global pharmaceutical supply chain requires absolute reliability. Volatility in intermediate precursor chemical markets can trigger severe API shortages. Gentolex addresses this by enforcing complete backward integration—synthesizing key starting materials (KSMs) in-house. This strategy isolates our global enterprise clients from pricing surges and material bottlenecks.
Global health authorities (US FDA, EMA, PMDA, NMPA) have heightened scrutiny over nitrosamine impurities, elemental impurities (ICH Q3D), and residual solvents (ICH Q3C). Our Hydroxychloroquine Sulphate raw powder is subjected to state-of-the-art LC-MS/MS and ICP-MS testing, guaranteeing zero detectable nitrosamine contamination.
Modern tablet manufacturing processes demand precise bulk density, particle size distribution (PSD), and powder flowability. We offer customized particle engineering, providing micronized Hydroxychloroquine Sulphate tailored for direct compression formulation lines to maximize dissolution kinetics.
Connecting global healthcare demands with high-standard Chinese chemical synthesis infrastructure.
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa.
Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
Our overall factory construction area spans 250,000 square meters under international standard to offer flexible, scalable and cost-effective solutions for clients globally.
Operational insights for drug product developers, pharmaceutical formulators, and generic drug manufacturers.
Hydroxychloroquine Sulphate is the cornerstone maintenance therapy for Systemic Lupus Erythematosus (SLE) and active Rheumatoid Arthritis (RA). Formulators rely on our high-purity API to ensure consistent bioavailability, minimal gastrointestinal side-effects, and long-term dose stability in film-coated 200mg and 400mg tablet formulations.
Widely deployed in malaria-endemic regions across LATAM, Africa, and Southeast Asia. Our raw powder meets international WHO pre-qualification standard benchmarks, allowing regional health authorities and generic pharmaceutical vendors to produce affordable, high-efficacy antimalarial treatments.
Emerging clinical trials evaluate Hydroxychloroquine Sulphate in combination with immunosuppressive adjuncts or metabolic regulators. Our custom mesh sizing guarantees excipient compatibility with microcrystalline cellulose, lactose monohydrate, and magnesium stearate during dry granulation.
Latest developments in peptide API manufacturing, high-purity biological synthesis, and global procurement trends.
Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient composed of the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Developed for specialized neuropharmacological applications...
View Details
As a professional Thymosin Beta-4 API manufacturer, we provide reliable bulk peptide raw material solutions for pharmaceutical research organizations and commercial biotech institutions...
View Details
BPC-157 API is a synthetic pentadecapeptide investigated for tissue repair, gastrointestinal cellular protection, and inflammatory regulation mechanisms...
View Details
Semax peptide raw material derived from ACTH fragment research. Supporting life science investigation and specialized dynamic therapeutic studies worldwide...
View Details
SS-31 (Elamipretide) API targets cardiolipin in the inner mitochondrial membrane, stabilizing mitochondrial bioenergetics for advanced cell research...
View DetailsExplore our full line of small molecules, peptide APIs, and chemical intermediates.
Serving pharmaceutical manufacturers across North America, Europe, LATAM, Africa, and Asia-Pacific.










Direct technical and regulatory answers for chemical buyers, Quality Assurance managers, and supply chain directors.